(Q46513264)

22 December 2017

title

Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone (English)

1 reference

22 December 2017

1 reference

1 reference

Paul Mulder

1 reference

22 December 2017

Virginie Mellin

1 reference

22 December 2017

Julie Favre

1 reference

22 December 2017

Magali Vercauteren

1 reference

22 December 2017

Isabelle Remy-Jouet

1 reference

22 December 2017

Christelle Monteil

1 reference

22 December 2017

Vincent Richard

1 reference

22 December 2017

Sylvanie Renet

1 reference

22 December 2017

Jean Paul Henry

1 reference

22 December 2017

Arco Y Jeng

1 reference

22 December 2017

Randy L Webb

1 reference

22 December 2017

Christian Thuillez

1 reference

22 December 2017

publication date

27 June 2008

1 reference

22 December 2017

published in

European Heart Journal

1 reference

22 December 2017

volume

1 reference

22 December 2017

issue

1 reference

22 December 2017

page(s)

2171-2179

1 reference

22 December 2017

Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Role of reactive oxygen species in cocaine-induced cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Nongenomic vascular action of aldosterone in the glomerular microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

Oxygen reduction by nitric-oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN277

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHN277

1 reference

22 December 2017

release_pgkmw4vn3jedpnfc2c2moodaga

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pgkmw4vn3jedpnfc2c2moodaga

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

22 December 2017